Actuate Therapeutics Inc. (ACTU)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 61
+0.11
+21%
$
14.6M Market Cap
- P/E Ratio
- Div Yield
890,100 Volume
- Eps
$ 0.5
Previous Close Investors:
Want to track ACTU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Actuate Therapeutics Inc. (ACTU) Statistics
Valuation metrics
Market Cap 14.6M
Enterprise value 10.51M
Trailing P/E (ttm) -0.68
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 14.6
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.51
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 539.08K
Average volume (90 days) 340.64K
Price summary
52-Week low 0.41
52-Week high 8.2
Beta -
50-Day moving average 0.93
200-Day moving average 1.66
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -3.93%
Return on equity -3.46%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.41
Current ratio (mrq) 1.25%
Book value per share (mrq) 0.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
